In addition, both HIF2α and CD36 were significantly overexpressed within the liver of NAFLD patients and, interestingly, a significant positive correlation between hepatic transcript levels of CD36 and erythropoietin (EPO), a HIF2α ‐dependent gene target, was observed in NAFLD patients. Here, EPAS1 is linked to metabolic dysfunction-associated steatotic liver disease.